RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is offering a share exchange program to its common stock shareholders. Lifeline Biotechnologies, Inc. will offer to exchange its Series B Convertible Preferred Stock, to be valued by the Company at $1.00 per share, for common shares of stock held by its shareholders as of the record date, which the Company is valuing at $.001 per share, a premium to the current market price. This means for every 1,000 shares of common stock submitted to the Company for exchange, shareholders will receive one share of Series B Convertible Preferred Stock valued at $1.00 for future conversion purposes.
